Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 301–400 of 2,013
Neuroprotective effects of dietary restriction: Evidence and mechanisms
Pani, G. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.004 · Cited by 103
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation
Bonelli, M. A., Monica, S. L., Fumarola, C., & Alfieri, R. R. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113676 · Cited by 112
Cellular hallmarks of aging emerge in the ovary prior to primordial follicle depletion
Ansere, V. A., Ali-Mondal, S., Sathiaseelan, R., Garcia, D. N., Isola, J. V. V., Henseb, J. D., Saccon, T. D., Ocañas, S. R., Tooley, K. B., Stout, M. B., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111425 · Cited by 101
Biophysical and biomolecular determination of cellular age in humans
Phillip, J. M., Wu, P.-H., Gilkes, D. M., Williams, W. A., McGovern, S., Daya, J., Chen, J., Aifuwa, I., Lee, J. S. H., Fan, R., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0093 · Cited by 109
Bonventre, J. V. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.8 · Cited by 110
“13 In a very interesting experiment, Baker et al. 27 created a mouse with a novel transgene, INK-ATTAC, which allowed the investigators to inducibly delete cells that expressed p16 INK4a , a senescence marker, in the BubR1 progeroid mouse background.”
BackgroundSenescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury
Aoshiba, K., Tsuji, T., Kameyama, S., Itoh, M., Semba, S., Yamaguchi, K., & Nakamura, H. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.04.001 · Cited by 100
“Recently, DSBs have attracted much attention as a trigger for the secretion of various mediators (senescence-associated secretory phenotype; SASP), which modify inflammation, tissue repair, fibrosis and carcinogenesis (Acosta et al., 2008; Freund et al., 2010; Kuilman et al., 2008, 2010; Rodier et al., 2009; Rodier an…”
BackgroundRegulation of lipids is central to replicative senescence
Lizardo, D. Y., Lin, Y., Gökçümen, Ö., & Atilla‐Gokcumen, G. E. (2017) · Molecular BioSystems · doi:10.1039/c6mb00842a · Cited by 106
Li, Z., Jiang, K., Zhu, X., Lin, G., Song, F., Zhao, Y., Piao, Y., Liu, J., Cheng, W., Bi, X., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.015 · Cited by 107
The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1
Samarakoon, R., Higgins, S. P., Higgins, C. E., & Higgins, P. J. (2019) · Biomolecules · doi:10.3390/biom9080341 · Cited by 101
Conserved senescence associated genes and pathways in primary human fibroblasts detected by RNA-seq
Marthandan, S., Baumgart, M., Priebe, S., Groth, M., Schaer, J., Kaether, C., Guthke, R., Cellerino, A., Platzer, M., Diekmann, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154531 · Cited by 91
“Furthermore, senescent cells are involved in in vivo aging due to their adverse impact on function and renewal of stem cells [4].”
BackgroundConstitutive HER2 Signaling Promotes Breast Cancer Metastasis through Cellular Senescence
Angelini, P. D., Fluck, M. F. Z., Pedersen, K., Parra-Palau, J. L., Guiu, M., Morales, C. B., Vicario, R., Luque-García, A., Navalpotro, N. P., Giralt, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2301 · Cited by 111
“presence of protumorigenic factors in the senescence secretome has led several authors to propose that, under certain circumstances, OIS may contribute to tumor progression in a cell nonautonomous manner (4, 5).”
BackgroundVenturelli, S., Berger, A., Weiland, T., Eßmann, F., Waibel, M., Nuebling, T., Häcker, S., Schenk, M., Schulze‐Osthoff, K., Salih, H. R., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0137 · Cited by 108
“org Mol Cancer Ther; 12(10) October 2013 2233”
BackgroundInfluentialRPE cell senescence: A key contributor to age-related macular degeneration
Kozlowski, M. R. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.01.018 · Cited by 110
Zingoni, A., Cecere, F., Vulpis, E., Fionda, C., Molfetta, R., Soriani, A., Petrucci, M. T., Ricciardi, M. R., Fuerst, D., Amendola, M. G., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402643 · Cited by 100
“A large body of evidence describes an increased expression of several metalloproteinases in cells undergoing senescence and developing a senescence-associated secretory phenotype (SASP) (37).”
BackgroundInfluentialFilippi‐Chiela, E. C., Silva, M. M. B. E., Thomé, M. P. M., & Lenz, G. (2015) · Autophagy · doi:10.1080/15548627.2015.1009795 · Cited by 114
“Senescence can be triggered by cell aging, oncogenic activation or in response to drugs that affect DNA and mitochondria, among other cell components.(23,29) Senescence establishment is driven by proteins that control the cell cycle and the stress response, such as the TP53, CDKN1A/p21, CDKN1B/p27, and CDKN2A/INK4/ARF…”
BackgroundPanebianco, C., Oben, J. A., Vinciguerra, M., & Pazienza, V. (2016) · Clinical and Experimental Medicine · doi:10.1007/s10238-016-0438-x · Cited by 111
“Although long considered a mechanism to prevent proliferation of mutated cells, it is now clear that senescence may also play the opposite role, triggering tumor development and progression [45, 48, 49].”
BackgroundVascular Smooth Muscle Cells Contribute to Atherosclerosis Immunity
Hu, D., Yin, C., Luo, S., Habenicht, A. J. R., & Mohanta, S. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01101 · Cited by 109
“VSMCs release cytokines to stimulate adjacent ECs to express adhesion molecules and release cytokines, and/or enhance chemotaxis of monocyte/macrophages into the plaque (3, 34, 35) (Table 1).”
BackgroundMorphological and Functional Characteristic of Senescent Cancer Cells
Sikora, E., Mosieniak, G., & Śliwińska, M. A. (2016) · Current Drug Targets · doi:10.2174/1389450116666151019094724 · Cited by 108
Chronic inflammation and aging: DNA damage tips the balance
Cavanagh, M. M., Weyand, C. M., & Goronzy, J. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.04.003 · Cited by 99
“Recent studies suggest that this apparent paradox is the result of changes to a number of basic mechanisms that are compounded with increasing age: increased DNA damage and decreased telomere length in HSCs resulting in chronic DNA repair responses; decreased reliance of adaptive immunity on specific antigen stimuli a…”
BackgroundInfluentialWhole Brain Radiation-Induced Vascular Cognitive Impairment: Mechanisms and Implications
Warrington, J. P., Ashpole, N. M., Csiszár, A., Lee, Y. W., Ungvari, Z. I., & Sonntag, W. E. (2013) · Journal of Vascular Research · doi:10.1159/000354227 · Cited by 103
The Menin–Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis
Kuwahara, M., Suzuki, J., Tofukuji, S., Yamada, T., Kanoh, M., Matsumoto, A., Maruyama, S., Kometani, K., Kurosaki, T., Ohara, O., et al. (2014) · Nature Communications · doi:10.1038/ncomms4555 · Cited by 98
A new mouse model of frailty: the Cu/Zn superoxide dismutase knockout mouse
Deepa, S. S., Bhaskaran, S., Espinoza, S. E., Brooks, S. V., McArdle, A., Jackson, M. J., Remmen, H. V., & Richardson, A. G. (2017) · GeroScience · doi:10.1007/s11357-017-9975-9 · Cited by 103
“Social world (interest and interactions with others) (for reviews see Coppé et al. 2010 and Rodier and Campisi 2011).”
BackgroundVenkatachalam, G., Surana, U., & Clement, M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx684 · Cited by 113
“These changes are necessary for the permanent halt of proliferation, failing which cells might escape from senescence to a pro-oncogenic state (5,18).”
BackgroundInfluentialRole of Plasminogen Activator Inhibitor-1 in Senescence and Aging
Eren, M., Boe, A. E., Klyachko, E. A., & Vaughan, D. E. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1387883 · Cited by 107
Ink4‐Arf locus in cancer and aging
Sherr, C. J. (2012) · WIREs Developmental Biology · doi:10.1002/wdev.40 · Cited by 98
Waaijer, M. E. C., Gunn, D. A., Adams, P. D., Pawlikowski, J. S., Griffiths, C. E. M., van Heemst, D., Slagboom, P. E., Westendorp, R. G. J., & Maier, A. B. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv114 · Cited by 98
Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria
Chiodi, I., & Mondello, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00133 · Cited by 109
“Below a threshold length, telomeres activate DNA double strand break checkpoints, leading to cellular senescence, a permanent replicative arrest, or to cell death trough apoptosis (van Steensel et al., 1998; Masutomi et al., 2003; Rodier and Campisi, 2011).”
BackgroundEndothelial cell senescence and thrombosis: Ageing clots
Bochenek, M. L., Schütz, E., & Schäfer, K. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.09.019 · Cited by 96
A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence
Ghosh, A. K., Rai, R., Park, K. E., Eren, M., Miyata, T., Wilsbacher, L. D., & Vaughan, D. E. (2016) · Oncotarget · doi:10.18632/oncotarget.12494 · Cited by 97
“In order to understand the signaling pathways involved in TM5441-mediated suppression of Doxorubicin-induced fibroblast senescence, we examined ERK1/2-MAPK, AMPK and GSK3α/β pathways which are known to be involved in Doxorubicin-induced senescence and apoptosis [1, 2, 5, 6].”
BackgroundInfluentialRadiation-inducible Immunotherapy for Cancer: Senescent Tumor Cells as a Cancer Vaccine
Meng, Y., Efimova, E. V., Hamzeh, K. W., Darga, T. E., Mauceri, H. J., Fu, Y.-X., Kron, S. J., & Weichselbaum, R. R. (2012) · Molecular Therapy · doi:10.1038/mt.2012.19 · Cited by 94
Oxidative Stress-Induced Cellular Senescence: Is Labile Iron the Connecting Link?
Nousis, L., Kanavaros, P., & Barbouti, A. (2023) · Antioxidants · doi:10.3390/antiox12061250 · Cited by 116
“However, the prolonged accumulation of senescent cells within tissues and organs can be maladapted, contributing to a wide spectrum of age-related diseases [2,3,6].”
BackgroundSoriani, A., Iannitto, M. L., Ricci, B., Fionda, C., Malgarini, G., Morrone, S., Peruzzi, G., Ricciardi, M. R., Petrucci, M. T., Cippitelli, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400271 · Cited by 104
“Induction of cellular senescence by chemotherapeutic agents has also emerged as a promising weapon to prevent cancer cell proliferation (4, 63).”
BackgroundBonafè, M., Storci, G., & Franceschi, C. (2012) · BioEssays · doi:10.1002/bies.201100104 · Cited by 94
“However, the in vivo role of senescent cells, and their contribution to the ageing phenotype at the tissue/organ level, remains unclear [14, 66].”
InfluentialEarly Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
Dai, L., Qureshi, A. R., Witasp, A., Lindholm, B., & Stenvinkel, P. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.015 · Cited by 94
ATRX is a regulator of therapy induced senescence in human cells
Kovatcheva, M., Liao, W., Klein, M. E., Robine, N., Geiger, H., Crago, A. M., Dickson, M. A., Tap, W. D., Singer, S., & Koff, A. (2017) · Nature Communications · doi:10.1038/s41467-017-00540-5 · Cited by 89
A New View of Pathway-Driven Drug Resistance in Tumor Proliferation
Nussinov, R., Tsai, C., & Jang, H. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.02.001 · Cited by 102
“Based on the oncogenic addiction paradigm [25], once proliferation has been stopped, cells can enter senescence [26] or quiescence (G0 phase of the cell cycle).”
BackgroundmTORC1 and p53: Clash of the gods?
Hasty, P., Sharp, Z. D., Curiel, T. J., & Campisi, J. (2012) · Cell Cycle · doi:10.4161/cc.22912 · Cited by 100
Self-citationTelomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition?
Polettini, J., Behnia, F., Taylor, B. D., Saade, G. R., Taylor, R. N., & Menon, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137188 · Cited by 93
“We posit that the inflammatory milieu generated by senescent cells [17,18] activates functional progesterone withdrawal, produces uterotonins and signals parturition.”
BackgroundHendrayani, S., Al‐Khalaf, H. H., & Aboussekhra, A. (2013) · Neoplasia · doi:10.1593/neo.13478 · Cited by 99
“Senescent human cells exhibit numerous changes in gene expression, many of which relate to the growth arrest [18].”
BackgroundSenescent Cells Contribute to the Physiological Remodeling of Aged Lungs
Calhoun, C., Shivshankar, P., Saker, M., Sloane, L. B., Livi, C. B., Sharp, Z. D., Orihuela, C. J., Adnot, S., White, E. S., Richardson, A., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu241 · Cited by 92
“Most likely, the senescent cells contribute to the remodeling in aged lungs by their SASP.”
BackgroundInfluentialFellows, C. R., Williams, R., Davies, I. R., Gohil, K., Baird, D. M., Fairclough, J. A., Rooney, P., Archer, C. W., & Khan, I. M. (2017) · Scientific Reports · doi:10.1038/srep41421 · Cited by 92
“Studies have also shown that alterations in the secretome of chondrocytes occurs upon senescence with increased production of pro-inflammatory cytokines and matrix metalloproteinases 34 .”
BackgroundCellular Senescence in Ageing, Age-Related Disease and Longevity
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2013) · Current Vascular Pharmacology · doi:10.2174/1570161111666131219094045 · Cited by 103
Epigenetic Mechanisms Impacting Aging: A Focus on Histone Levels and Telomeres
Song, S., & Johnson, F. B. (2018) · Genes · doi:10.3390/genes9040201 · Cited by 101
“Cell senescence is characterized by both a permanent arrest of cell division but maintained cellular viability, and by profound changes in cellular gene expression and physiology, including the secretion of inflammatory cytokines and proteases collectively called the SASP (senescence-associated secretory phenotype [15…”
BackgroundG3BP1 controls the senescence-associated secretome and its impact on cancer progression
Omer, A., Cruz-Barrera, M., Moran, J. L., Lian, X. J., Marco, S. D., Beausejour, C. M., & Gallouzi, I. (2020) · Nature Communications · doi:10.1038/s41467-020-18734-9 · Cited by 100
Age and Sex: Impact on adipose tissue metabolism and inflammation
Varghese, M., Song, J., & Singer, K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111563 · Cited by 109
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
Jia, W. P., Rajani, C., Xu, H., & Zheng, X. (2020) · Protein & Cell · doi:10.1007/s13238-020-00748-0 · Cited by 96
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Guillon, J., Petit, C., Moreau, M., Toutain, B., Henry, C., Roché, H., Bonichon-Lamichhane, N., Salmon, J. P., Lemonnier, J., Campone, M., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1406-7 · Cited by 90
Cancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 101
Astrocytes autophagy in aging and neurodegenerative disorders
Wang, J., & Xu, C. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109691 · Cited by 95
Telomere length: how the length makes a difference
Lulkiewicz, M., Bajsert, J., Kopczynski, P., Barczak, W., & Rubiś, B. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05551-y · Cited by 102
“Additionally, a proinflammatory secretome (cytokines and matrix metalloproteinases) are also recognized as the senescence-associated secretory phenotype that may also contribute to aging [7, 8].”
BackgroundThe role of hydrogen sulfide in aging and age-related pathologies
Perridon, B. W., Leuvenink, H. G. D., Hillebrands, J., van Goor, H., & Bos, E. M. (2016) · Aging · doi:10.18632/aging.101026 · Cited by 96
“The changed secretome of senescent cells is an example of such an alteration in the paracrine interaction between cells [15, 226, 227, 244].”
BackgroundAndrade, B., Jara‐Gutiérrez, C., Paz-Araos, M., Vázquez, M. C., Díaz, P., & Murgas, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315182 · Cited by 101
“In this way, during Inflammaging, ROS production is exacerbated, as well as cytokines generation, all of which alter the phenotypes of the macrophages surrounding cells and induce the normal tissue function detriment [59].”
BackgroundNon-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
Suzuki, J., Yamada, T., Inoue, K., Nabe, S., Kuwahara, M., Takemori, N., Takemori, A., Matsuda, S., Kanoh, M., Imai, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05854-6 · Cited by 98
Zampetidis, C., Galanos, P., Angelopoulou, A., Zhu, Y., Polyzou, A., Karamitros, T., Kotsinas, A., Lаgopati, N., Mourkioti, I., Mirzazadeh, R., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.017 · Cited by 99
Linking JNK Activity to the DNA Damage Response
Picco, V., & Pagès, G. (2013) · Genes & Cancer · doi:10.1177/1947601913486347 · Cited by 93
“If the damage is irreparable or incorrectly resolved, cells stop proliferating definitely and are directed towards apoptosis or senescence.(16,46) NF-κB activity is usually described as a prosurvival factor driving resistance to anticancer drug therapies and thus fits well as a factor to promote cell survival during t…”
BackgroundTakebayashi, S., Tanaka, H., Hino, S., Nakatsu, Y., Igata, T., Sakamoto, A., Narita, M., & Nakao, M. (2015) · Aging Cell · doi:10.1111/acel.12351 · Cited by 84
“…Graduate Schools ‘HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program’, Kumamoto University, Kumamoto, Japan 3Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK 4Core Research for Evolutional Science and Technology (CREST),…”
BackgroundLewińska, A., Adamczyk‐Grochala, J., Kwasniewicz, E., Deręgowska, A., Semik‐Gurgul, E., Ząbek, T., & Wnuk, M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.012 · Cited by 95
Pathogenesis of wound healing disorders in the elderly
Makrantonaki, E., Wlaschek, M., & Scharffetter‐Kochanek, K. (2017) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13199 · Cited by 103
Is exercise a senolytic medicine? A systematic review
Chen, X., Yi, Z., Wong, G. T., Hasan, K. M. M., Kwan, J. S., Ma, A. C., & Chang, R. C. (2021) · Aging Cell · doi:10.1111/acel.13294 · Cited by 88
mTOR: A Potential Therapeutic Target in Osteoarthritis?
Pal, B., Endisha, H., Zhang, Y., & Kapoor, M. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0082-z · Cited by 90
“cellular hypertrophy) [25, 26].”
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2016) · Biogerontology · doi:10.1007/s10522-016-9655-7 · Cited by 94
“Cellular senescence represents an irreversible growth arrest of proliferating cells and thus acts as a tumor suppressor (Campisi 2005; Collado et al. 2007; Rodier and Campisi 2011).”
Differential senescence in feto-maternal tissues during mouse pregnancy
Bonney, E. A., Krebs, K., Saade, G., Kechichian, T., Trivedi, J., Huaizhi, Y., & Menon, R. (2016) · Placenta · doi:10.1016/j.placenta.2016.04.018 · Cited by 86
“Senescence is the process of cellular aging by which cells change morphologically (size, shape, and organelle structure[12, 13]), in gene (p16Ink4[14], and p21[10]) and protein (beta gal[15]) expression, and in the activation of key signaling constituents, such as p38[16] and p53 [17, 18] that can determine the fate o…”
BackgroundHIV-associated cellular senescence: A contributor to accelerated aging
Cohen, J., & Torres, C. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.004 · Cited by 99
“damage, heterochromatin formation, and the secretion of pro-inflammatory cytokines and proteases known as the senescence-associated secretory phenotype (SASP) (Rodier and Campisi, 2011).”
InfluentialInsomnia and Telomere Length in Older Adults
Carroll, J. E., Esquivel, S., Goldberg, A., Seeman, T. E., Effros, R. B., Dock, J., Olmstead, R., Breen, E. C., & Irwin, M. R. (2016) · Sleep · doi:10.5665/sleep.5526 · Cited by 85
Mitterberger, M. C., Lechner, S., Mattesich, M., & Zwerschke, W. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt043 · Cited by 87
“There is evidence that the accumulation of senescent cells can lead to a functional decline of tissues because of their detrimental secretory phenotype (3).”
InfluentialSenescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity
Vernot, J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00063 · Cited by 86
Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury
Wan, Y., McDaniel, K. M., Wu, N., Ramos‐Lorenzo, S., Glaser, T., Venter, J. K., Francis, H., Kennedy, L. L., Sato, K., Zhou, T., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.027 · Cited by 90
“Although senescence is a well-known mechanism of tumor suppression, emerging evidence has indicated that it may play a role in aging, tissue repair, and even malignancy.(15) Cellular senescence of hepatocytes, cholangiocytes, HSCs, and immune cells has been shown in a wide spectrum of chronic liver disorders.”
BackgroundCellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 92
“Firstly, senescence can drive ageing by depleting stem cells, which are the source of cell replenishment, as they accumulate DNA damage [94,102].”
BackgroundMenendez, J. A., Cufí, S., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., Vellon, L., & Vazquez-Martin, A. (2011) · Aging · doi:10.18632/aging.100407 · Cited by 85
“Senescent cells accumulate in various tissues and organs with aging and have been hypothesized to disrupt tissue structure and function [120-122].”
BackgroundRen, C., Cheng, X., Lu, B., & Yang, G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.140 · Cited by 75
“Cellular senescence has been a featured link between inflammation and tumourigenesis [32].”
BackgroundCrosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.
Imai, Y., Takahashi, A., Hanyu, A., Hori, S., Sato, S., Naka, K., Hirao, A., Ohtani, N., & Hara, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.006 · Cited by 84
miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence
Si, H., Yang, T.-M., Li, L., Tian, M., Zhou, L., Li, D.-P., Huang, Q., Kang, P., Yang, J., Zhou, Z.-K., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.10.032 · Cited by 88
“As chondrocytes in the AC of adults do not normally proliferate,(31) it is unlikely that chondrocyte senescence results from multiple cycles of cell proliferation; therefore, repetitive stress stimulation may be the main cause.(10,32) In addition to the spontaneous senescence of aging, many stressful events, such as i…”
BackgroundAdvances in Enteric Neurobiology: The “Brain” in the Gut in Health and Disease
Kulkarni, S., Ganz, J., Bayrer, J. R., Becker, L. S., Bogunovic, M., & Rao, M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1663-18.2018 · Cited by 90
“…have been proposed as the cause for inflammaging, including increased production of proinflammatory cytokines due to a rise in senescent cells (Rodier and Campisi, 2011), alterations in the gut microbiota (Claesson et al., 2012; Thevaranjan et al., 2017), and changes to immune cells…”
BackgroundBolinches-Amorós, A., Mollá, B., Pla-MartÃn, D., Palau, F., & González-Cabo, P. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00124 · Cited by 84
Huang, Y.-H., Yang, P., Chuah, Q.-Y., Lee, Y., Hsieh, Y.-F., Peng, C.-W., & Chiu, S.-J. (2014) · Autophagy · doi:10.4161/auto.28772 · Cited by 88
Tsuji, S., Minami, S., Hashimoto, R., Konishi, Y., Suzuki, T., Kondo, T., Sasai, M., Torii, S., Ono, C., Shichinohe, S., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00170-7 · Cited by 84
Influence of the Mediterranean Diet on Healthy Aging
Andreo-López, M. C., Contreras-Bolívar, V., Muñoz‐Torres, M., García-Fontana, B., & García‐Fontana, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054491 · Cited by 105
“In addition, these cells produce a proinflammatory secretome or SASP that contributes to aging [242,243].”
BackgroundA Different Facet of p53 Function: Regulation of Immunity and Inflammation During Tumor Development
Shi, D., & Jiang, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.762651 · Cited by 92
“Moreover, the activation of NF-κB promotes the secretion of numerous inflammatory cytokines and chemokines in senescent cells with highly activated p53 (Rodier and Campisi, 2011; Davalos et al., 2013).”
BackgroundRecent Advances in Understanding Werner Syndrome
Shamanna, R. A., Croteau, D. L., Lee, J., & Bohr, V. A. (2017) · F1000Research · doi:10.12688/f1000research.12110.1 · Cited by 96
Byun, H., Lee, Y., Kim, J., & Yoon, G. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.122 · Cited by 81
“creted by senescent cells (23); this implies that the SASP component expression may be sequentially regulated in a hierarchal cascade through their autocrine activity.”
BackgroundAlqahtani, S., Alqahtani, T., Venkatesan, K., Sivadasan, D., Ahmed, R., Sirag, N., Elfadil, H., Mohamed, H. A., A, H., Ahmed, R. E., et al. (2025) · Cells · doi:10.3390/cells14080608 · Cited by 108
“Modulating the SASP, reducing its inflammatory components while retaining regenerative effects, offers therapeutic potential for tissue rejuvenation and homeostasis [37], necessitating deeper insights into its composition, dynamics, and tissue-specific actions.”
Murai, S., Ando, A., Ebara, S., Hirayama, M., Satomi, Y., & Hara, T. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.34 · Cited by 87
Targeting immunosenescence and inflammaging: advancing longevity research
Nguyen, T. Q. T., & Cho, K. A. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01527-9 · Cited by 114
“DAMPs, released due to cellular stress, further impair tissue repair mechanisms and immune function, compounding the effects of aging and making tissues more susceptible to these diseases 44,45 .”
Mitochondrial DNA damage induces apoptosis in senescent cells
Laberge, R.-M., Adler, D., DeMaria, M., Mechtouf, N., Teachenor, R., Cardin, G. B., Desprez, P.-Y., Campisi, J., & Rodier, F. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.199 · Cited by 82
“Additionally, the ability of senescent cells to secrete inflammatory molecules might contribute to tissue repair, but persistent senescent cells might drive chronic inflammation, a major risk factor for age-related pathologies.(6) Most senescent cells express the p16 tumor-suppressor protein, which also increases with…”
BackgroundSelf-citationThioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases
Yang, B., Lin, Y., Huang, Y., Shen, Y.-Q., & Chen, Q. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103032 · Cited by 99
“B. Yang et al. long-term and irreversible process contributes significantly to age-related changes [73].”
BackgroundSex differences in the associations of placental epigenetic aging with fetal growth
Tekola-Ayele, F., Workalemahu, T., Gorfu, G., Shrestha, D., Tycko, B., Wapner, R., Zhang, C., & Louis, G. M. B. (2019) · Aging · doi:10.18632/aging.102124 · Cited by 81
Kaur, E., Rajendra, J., Jadhav, S., Shridhar, E., Goda, J. S., Moiyadi, A. V., & Dutt, S. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv050 · Cited by 84
“In an independent study, we performed transcriptome analysis of RR population (unpublished data) and found up-regulation of SASPs in the RR cells.”
BackgroundInfluentialIs DNA damage indispensable for stress-induced senescence?
Bielak-Żmijewska, A., Mosieniak, G., & Sikora, E. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.004 · Cited by 92
Preininger, M. K., & Kaufer, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116217 · Cited by 92
Aging, Cellular Senescence, and Progressive Multiple Sclerosis
Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00178 · Cited by 79
“The number of senescent cells increases with age (Rodier and Campisi, 2011).”
BackgroundHonda, S., Ikeda, K., Urata, R., Yamazaki, E., Emoto, N., & Matoba, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-94097-5 · Cited by 95
Faheem, M. M., Seligson, N. D., Ahmad, S. M., Rasool, R. U., Gandhi, S. G., Bhagat, M., & Goswami, A. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0286-z · Cited by 92
Transcriptome analysis of ageing in uninjured human Achilles tendon
Peffers, M. J., Fang, Y., Cheung, K., Wei, T. K. J., Clegg, P., & Birch, H. L. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0544-2 · Cited by 84
“A senescence phenotype has been described, although no marker of senescence identified thus far is entirely specific to the senescent state [9].”
BackgroundSmitherman, A. B., Wood, W. A., Mitin, N., Ayer Miller, V. L., Deal, A. M., Davis, I. J., Blatt, J., Gold, S. H., & Muss, H. B. (2020) · Cancer · doi:10.1002/cncr.33112 · Cited by 80
“Accumulation of senescent cells is a hallmark of human aging.(9,10) In response to persistent DNA damage, cellular senescence occurs through the activation of the INK4a/ARF (CDKN2a) locus on chromosome 9p21.”
BackgroundQian, R., Ding, L., Yan, L., Lin, M., & Ju, H. (2014) · Analytical Chemistry · doi:10.1021/ac502538w · Cited by 80
Dander, E., Palmi, C., D’Amico, G., & Cazzaniga, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094426 · Cited by 87
“These molecules constitute the senescence-associated secretory phenotype (SASP), and they are able to influence the surrounding microenvironment [42].”
BackgroundFrailty biomarkers under the perspective of geroscience: A narrative review
Gonçalves, R. S. D. S. A., Maciel, Á. C. C., Rolland, Y., Vellas, B. J., & Barreto, P. D. S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101737 · Cited by 97
Implications of Oxidative Stress and Cellular Senescence in Age-Related Thymus Involution
Barbouti, A., Vasileiou, P. V. S., Evangelou, K., Vlasis, K. G., Papoudou‐Bai, A., Gorgoulis, V. G., & Kanavaros, P. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7986071 · Cited by 90
Mazzoni, M., Mauro, G., Erreni, M., Romeo, P., Minna, E., Vizioli, M. G., Belgiovine, C., Rizzetti, M. G., Pagliardini, S., Avigni, R., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1198-8 · Cited by 91
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.